You have 9 free searches left this month | for more free features.

GSK2798745

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Edema Trial in Australia, New Zealand, United States (GSK2798745)

Completed
  • Macular Edema
  • GSK2798745
  • Sacramento, California
  • +10 more
Aug 24, 2022

Healthy Volunteers Trial in Hannover (GSK2798745, Placebo, Lipoplysaccharide from Escherichia Coli)

Terminated
  • Healthy Volunteers
  • GSK2798745
  • +3 more
  • Hannover, Niedersachsen, Germany
    GSK Investigational Site
Feb 26, 2021

Cough Trial in United Kingdom (GSK2798745, Placebo)

Terminated
  • Cough
  • GSK2798745
  • Placebo
  • Manchester, Lancashire, United Kingdom
  • +7 more
Sep 6, 2019

Oedema, Pulmonary Trial in Cambridge, London (GSK2798745 solution, GSK2798745 suspension, GSK2798745 capsule)

Completed
  • Oedema, Pulmonary
  • GSK2798745 solution
  • +5 more
  • Cambridge, United Kingdom
  • +1 more
Sep 25, 2018

Heart Failure Trial in Minneapolis, Rochester (GSK2798745, Placebo)

Completed
  • Heart Failure
  • GSK2798745
  • Placebo
  • Minneapolis, Minnesota
  • +1 more
Aug 7, 2018

CHF Trial in Overland Park (GSK2798745 Micronized API without SLS and hypermellose (Tablet A), GSK2798745 Micronized API with

Completed
  • Heart Failure, Congestive
  • GSK2798745 Micronized API without SLS and hypermellose (Tablet A)
  • +2 more
  • Overland Park, Kansas
    GSK Investigational Site
Jan 24, 2017